CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 195 of 644
Non-Antibody Products
Page 195 of 644
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| DL-erythro-PDMP (hydrochloride) | A PDMP mixture containing D-erythro (1S,2R) PDMP and L-erythro (1R,2S) PDM… | 100 mg | 22676-100 | More Info |
| DL-erythro-PPMP (hydrochloride) | A stereoisomer of DL-threo-PPMP; has no effect on glucosylceramide synthet… | 10 mg | 24524-10 | More Info |
| DL-erythro-PPMP (hydrochloride) | A stereoisomer of DL-threo-PPMP; has no effect on glucosylceramide synthet… | 100 mg | 24524-100 | More Info |
| DL-erythro-PPMP (hydrochloride) | A stereoisomer of DL-threo-PPMP; has no effect on glucosylceramide synthet… | 25 mg | 24524-25 | More Info |
| DL-erythro-PPMP (hydrochloride) | A stereoisomer of DL-threo-PPMP; has no effect on glucosylceramide synthet… | 5 mg | 24524-5 | More Info |
| DL-erythro Sphinganine (d20:0) | A mixture of naturally occurring sphinganine (d20:0) and synthetic L-eryth… | 10 mg | 24378-10 | More Info |
| DL-erythro/threo-Isocitric Acid (sodium salt hydrate) | A mixture of isocitric acid isomers | 1 g | 32541-1 | More Info |
| DL-erythro/threo-Isocitric Acid (sodium salt hydrate) | A mixture of isocitric acid isomers | 10 g | 32541-10 | More Info |
| DL-erythro/threo-Isocitric Acid (sodium salt hydrate) | A mixture of isocitric acid isomers | 5 g | 32541-5 | More Info |
| DL-erythro/threo-Isocitric Acid (sodium salt hydrate) | A mixture of isocitric acid isomers | 500 mg | 32541-500 | More Info |
| DL-erythro/threo Sphinganine (d16:0) | A mixture of sphinganine (d16:0), L-erythro sphinganine (d16:0), D-threo s… | 1 mg | 24376-1 | More Info |
| DL-erythro/threo Sphinganine (d16:0) | A mixture of sphinganine (d16:0), L-erythro sphinganine (d16:0), D-threo s… | 10 mg | 24376-10 | More Info |
| DL-erythro/threo Sphinganine (d16:0) | A mixture of sphinganine (d16:0), L-erythro sphinganine (d16:0), D-threo s… | 5 mg | 24376-5 | More Info |
| DL-erythro/threo Sphinganine (d18:0) | A mixture of sphinganine (d18:0), L-erythro sphinganine (d18:0), D-threo s… | 25 mg | 24367-25 | More Info |
| DL-Folinic Acid (calcium salt) | A formylated form of tetrahydrofolic acid, the reduced form of folic acid;… | 100 mg | 20383-100 | More Info |
| DL-Folinic Acid (calcium salt) | A formylated form of tetrahydrofolic acid, the reduced form of folic acid;… | 250 mg | 20383-250 | More Info |
| DL-Folinic Acid (calcium salt) | A formylated form of tetrahydrofolic acid, the reduced form of folic acid;… | 500 mg | 20383-500 | More Info |
| DL-Glyceraldehyde-3-phosphate | An intermediate in several metabolic pathways, including glycolysis and gl… | 10 mg | 17865-10 | More Info |
| DL-Glyceraldehyde-3-phosphate | An intermediate in several metabolic pathways, including glycolysis and gl… | 100 mg | 17865-100 | More Info |
| DL-Glyceraldehyde-3-phosphate | An intermediate in several metabolic pathways, including glycolysis and gl… | 25 mg | 17865-25 | More Info |
| DL-Glyceraldehyde-3-phosphate | An intermediate in several metabolic pathways, including glycolysis and gl… | 5 mg | 17865-5 | More Info |
| DL-Histidine-d3 | An internal standard for the quantification of histidine by GC- or LC-MS | 1 mg | 34841-1 | More Info |
| DL-Histidine-d3 | An internal standard for the quantification of histidine by GC- or LC-MS | 10 mg | 34841-10 | More Info |
| DL-Histidine-d3 | An internal standard for the quantification of histidine by GC- or LC-MS | 5 mg | 34841-5 | More Info |
| DL-Histidine-d3 | An internal standard for the quantification of histidine by GC- or LC-MS | 500 µg | 34841-500 | More Info |
| DL-Homocysteine | An amino acid; inhibits ACh-induced vasodilation of precontracted isolated… | 1 g | 30285-1 | More Info |
| DL-Homocysteine | An amino acid; inhibits ACh-induced vasodilation of precontracted isolated… | 500 mg | 30285-500 | More Info |
| DL-Homocysteine thiolactone (hydrochloride) | A derivative of DL-homocysteine; inhibits the growth of B. campestris, L.… | 100 g | 31466-100 | More Info |
| DL-Homocysteine thiolactone (hydrochloride) | A derivative of DL-homocysteine; inhibits the growth of B. campestris, L.… | 250 g | 31466-250 | More Info |
| DL-Homocysteine thiolactone (hydrochloride) | A derivative of DL-homocysteine; inhibits the growth of B. campestris, L.… | 50 g | 31466-50 | More Info |
| DL-Homocysteine thiolactone (hydrochloride) | A derivative of DL-homocysteine; inhibits the growth of B. campestris, L.… | 500 g | 31466-500 | More Info |
| DL-Homocystine | An oxidized dimeric form of homocysteine; inhibits CDNB-induced L-cystine… | 10 g | 36223-10 | More Info |
| DL-Homocystine | An oxidized dimeric form of homocysteine; inhibits CDNB-induced L-cystine… | 25 g | 36223-25 | More Info |
| DL-Homocystine | An oxidized dimeric form of homocysteine; inhibits CDNB-induced L-cystine… | 5 g | 36223-5 | More Info |
| DL-4662 (hydrochloride) | A 3,4-dimethoxy derivative of the substituted cathinones: pentedrone and &… | 10 mg | 9002077-10 | More Info |
| DL-4662 (hydrochloride) | A 3,4-dimethoxy derivative of the substituted cathinones: pentedrone and &… | 5 mg | 9002077-5 | More Info |
| DL-4662 (hydrochloride) | A 3,4-dimethoxy derivative of the substituted cathinones: pentedrone and &… | 50 mg | 9002077-50 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 10 mg | 36701-10 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 100 mg | 36701-100 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 25 mg | 36701-25 | More Info |
| DLin-DMA | An ionizable amino lipid; has been used in combination with other lipids i… | 250 mg | 36701-250 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 1 mg | 34363-1 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 10 mg | 34363-10 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 25 mg | 34363-25 | More Info |
| DLin-KC2-DMA | An ionizable cationic amino lipid (apparent pKa = 6.7); administration of… | 5 mg | 34363-5 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 1 mg | 39731-1 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 10 mg | 39731-10 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 25 mg | 39731-25 | More Info |
| DLin-MC2-DMA | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 5 mg | 39731-5 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 1 mg | 34364-1 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 10 mg | 34364-10 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 25 mg | 34364-25 | More Info |
| DLin-MC3-DMA | An ionizable cationic amino lipid (apparent pKa = 6.44); administration of… | 5 mg | 34364-5 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 1 mg | 39732-1 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 10 mg | 39732-10 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 25 mg | 39732-25 | More Info |
| DLin-MC4-DMA | An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and… | 5 mg | 39732-5 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 1 mg | 34842-1 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 10 mg | 34842-10 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 25 mg | 34842-25 | More Info |
| DL-Isoleucine-d10 | An internal standard for the quantification of isoleucine by GC- or LC-MS | 5 mg | 34842-5 | More Info |
| DL-Malic Acid | The racemate of L-malic acid; reduces IFN-γ and TNF-α-induced… | 100 g | 33310-100 | More Info |
| DL-Malic Acid | The racemate of L-malic acid; reduces IFN-γ and TNF-α-induced… | 250 g | 33310-250 | More Info |
| DL-Malic Acid | The racemate of L-malic acid; reduces IFN-γ and TNF-α-induced… | 50 g | 33310-50 | More Info |
| DL-Mevalonolactone | A precursor in the mevalonate pathway; induces depolarization and swelling… | 1 g | 20348-1 | More Info |
| DL-Mevalonolactone | A precursor in the mevalonate pathway; induces depolarization and swelling… | 250 mg | 20348-250 | More Info |
| DL-Mevalonolactone | A precursor in the mevalonate pathway; induces depolarization and swelling… | 500 mg | 20348-500 | More Info |
| DL-3-n-Butylphthalide | A phthalide with diverse biological activities; inhibits ADP-, thrombin-,… | 1 g | 30284-1 | More Info |
| DL-3-n-Butylphthalide | A phthalide with diverse biological activities; inhibits ADP-, thrombin-,… | 5 g | 30284-5 | More Info |
| DL-3-n-Butylphthalide | A phthalide with diverse biological activities; inhibits ADP-, thrombin-,… | 500 mg | 30284-500 | More Info |
| DL-Norephedrine (hydrochloride) | A psychoactive amphetamine that acts as a potent norepinephrine releasing… | 10 mg | 14212-10 | More Info |
| DL-Norephedrine (hydrochloride) | A psychoactive amphetamine that acts as a potent norepinephrine releasing… | 100 mg | 14212-100 | More Info |
| DL-Norephedrine (hydrochloride) | A psychoactive amphetamine that acts as a potent norepinephrine releasing… | 50 mg | 14212-50 | More Info |
| DL-o-Tyrosine | A phenylalanine hydroxylation product; has been used as a marker of irradi… | 100 mg | 33570-100 | More Info |
| DL-o-Tyrosine | A phenylalanine hydroxylation product; has been used as a marker of irradi… | 250 mg | 33570-250 | More Info |
| DL-o-Tyrosine | A phenylalanine hydroxylation product; has been used as a marker of irradi… | 500 mg | 33570-500 | More Info |
| DL-Phenyl-d5-alanine | An internal standard for the quantification of DL-phenylalanine by GC- or… | 1 g | 34845-1 | More Info |
| DL-Phenyl-d5-alanine | An internal standard for the quantification of DL-phenylalanine by GC- or… | 100 mg | 34845-100 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 1 mg | 10010948-1 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 10 mg | 10010948-10 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 5 mg | 10010948-5 | More Info |
| DL-Propargyl Glycine (hydrochloride) | An irreversible inhibitor of H2S synthesis; blocks H2S synthesis activity… | 50 mg | 10010948-50 | More Info |
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 100 g | 36375-100 | More Info |
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 250 g | 36375-250 | More Info |
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 50 g | 36375-50 | More Info |
| DL-Pyroglutamic Acid | A cyclized form of glutamic acid; decreases immobility time in the forced… | 500 g | 36375-500 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 1 mg | 34731-1 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 10 mg | 34731-10 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 25 mg | 34731-25 | More Info |
| DL-Sulforaphane Glutathione | A metabolite of sulforaphane; increases mRNA expression of GSTA1 and UGT1A… | 5 mg | 34731-5 | More Info |
| DL-Sulforaphane N-acetyl-L-cysteine | A major metabolite of sulforaphane that has been shown induce ARE-driven g… | 1 mg | 16098-1 | More Info |
| DL-Sulforaphane N-acetyl-L-cysteine | A major metabolite of sulforaphane that has been shown induce ARE-driven g… | 10 mg | 16098-10 | More Info |
| DL-Sulforaphane N-acetyl-L-cysteine | A major metabolite of sulforaphane that has been shown induce ARE-driven g… | 5 mg | 16098-5 | More Info |
| DL-TBOA | An EAAT inhibitor (IC50s = 67 and 5.5 µM for glutamate uptake in COS… | 10 mg | 29632-10 | More Info |
| DL-TBOA | An EAAT inhibitor (IC50s = 67 and 5.5 µM for glutamate uptake in COS… | 5 mg | 29632-5 | More Info |
| DL-threo-β-Hydroxyaspartic Acid | An EAAT inhibitor; inhibits glutamate uptake in COS-1 cells expressing hum… | 100 mg | 35274-100 | More Info |
| DL-threo-β-Hydroxyaspartic Acid | An EAAT inhibitor; inhibits glutamate uptake in COS-1 cells expressing hum… | 25 mg | 35274-25 | More Info |
| DL-threo-β-Hydroxyaspartic Acid | An EAAT inhibitor; inhibits glutamate uptake in COS-1 cells expressing hum… | 50 mg | 35274-50 | More Info |
| DL-threo-Isocitric Acid (sodium salt hydrate) | A racemic mixture of D-threo-isocitric acid and L-threo-isocitric acid; ha… | 1 g | 30378-1 | More Info |
| DL-threo-Isocitric Acid (sodium salt hydrate) | A racemic mixture of D-threo-isocitric acid and L-threo-isocitric acid; ha… | 500 mg | 30378-500 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile